soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm Reduces CV Events in T2DM – (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine 🧪 T2DM + ASCVD/CKD 💊 Oral semaglutide 14 mg vs placebo 📉 semaglutide cardiovascular outcomes trial Semaglutide

This toolkit directly supports research accuracy by eliminating the math errors, unit-conversion mistakes, and technique problems that compromise reconstitution

Semaglutide is available in two popular brand-name injections, which include: Ozempic Ozempic is FDA-approved for individuals with type 2 diabetes to help manage high blood sugar levels and lose weight

Patients should be educated on recognising and managing hypoglycaemia, and dose adjustments of concomitant diabetes medications may be necessary

One in five

Current treatments for diabetes and obesity include medications such as metformin, sulfonylureas, thiazolidinediones, glucagon-like peptide-1 agonists, and SGLT-2 inhibitors

According to the company's own disclosures, compounded medications are not evaluated by the FDA for safety, quality, or efficacy as finished products